AJP - Endo Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 281: E837-E847, 2001;
0193-1849/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (40)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guo, R.
Right arrow Articles by Quarles, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guo, R.
Right arrow Articles by Quarles, L. D.
Vol. 281, Issue 4, E837-E847, October 2001

Analysis of recombinant Phex: an endopeptidase in search of a substrate

Rong Guo, Shiguang Liu, Robert F. Spurney, and L. D. Quarles

Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710

X-linked hypophosphatemia (XLH) is caused by inactivating mutations of Phex, a phosphate-regulating endopeptidase. Further advances in our knowledge of the pathogenesis of XLH require identification of the biological function of Phex and its physiologically relevant substrates. We evaluated several potential substrates using mouse recombinant wild-type Phex proteins (rPhex-WT) and inactive mutant Phex proteins (rPhex-3'M) lacking the COOH-terminal catalytic domain as controls. By Western blot analysis, we demonstrated that Phex is a membrane-bound 100-kDa glycosylated monomer. Neither casein, a substrate for the related endopeptidase thermolysin, human stanniocalcin 1 (hSTC-1), an osteoblast-derived phosphate-regulating factor, nor FGF-23 peptide (amino acid 172-186), comprising the region mutated in autosomal dominant hypophosphatemia, was cleaved by rPhex-WT. In addition, membranes expressing rPhex-WT, rPhex-3'M, and the empty vector hydrolyzed parathyroid hormone-(1-34), indicating the lack of Phex-specific cleavage of parathyroid hormone. In contrast, rPhex-WT did display an EDTA-dependent cleavage of the neutral endopeptidase substrate [Leu]enkephalin. Further studies with wild-type and mutant rPhex proteins should permit the identification of physiologically relevant substrates involved in the pathogenesis of XLH.

X-linked hypophosphatemia; hypophosphatemia; rickets; parathyroid hormone; FGF-23; [Leu]enkephalin


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. Liu, J. Zhou, W. Tang, R. Menard, J. Q. Feng, and L. D. Quarles
Pathogenic role of Fgf23 in Dmp1-null mice
Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E254 - E261.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. Liu and L. D. Quarles
How Fibroblast Growth Factor 23 Works
J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1637 - 1647.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. Liu, W. Tang, J. Zhou, J. R. Stubbs, Q. Luo, M. Pi, and L. D. Quarles
Fibroblast Growth Factor 23 Is a Counter-Regulatory Phosphaturic Hormone for Vitamin D
J. Am. Soc. Nephrol., May 1, 2006; 17(5): 1305 - 1315.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
A. Syal, S. Schiavi, S. Chakravarty, V. Dwarakanath, R. Quigley, and M. Baum
Fibroblast growth factor-23 increases mouse PGE2 production in vivo and in vitro
Am J Physiol Renal Physiol, February 1, 2006; 290(2): F450 - F455.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
T. J. Berndt, S. Schiavi, and R. Kumar
"Phosphatonins" and the regulation of phosphorus homeostasis
Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1170 - F1182.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
S. M. Jan de Beur
Tumor-Induced Osteomalacia
JAMA, September 14, 2005; 294(10): 1260 - 1267.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
M. Baum, O. W. Moe, J. Zhang, V. Dwarakanath, and R. Quigley
Phosphatonin washout in Hyp mice proximal tubules: evidence for posttranscriptional regulation
Am J Physiol Renal Physiol, February 1, 2005; 288(2): F363 - F370.
[Abstract] [Full Text] [PDF]

Home page
 CROBMHome page
P. S.N. Rowe
THE WRICKKENED PATHWAYS OF FGF23, MEPE AND PHEX
Critical Reviews in Oral Biology & Medicine, September 1, 2004; 15(5): 264 - 281.
[Abstract] [Full Text] [PDF]

Home page
 CROBMHome page
C. Qin, O. Baba, and W.T. Butler
POST-TRANSLATIONAL MODIFICATIONS OF SIBLING PROTEINS AND THEIR ROLES IN OSTEOGENESIS AND DENTINOGENESIS
Critical Reviews in Oral Biology & Medicine, May 1, 2004; 15(3): 126 - 136.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Liu, R. Guo, L. G. Simpson, Z.-S. Xiao, C. E. Burnham, and L. D. Quarles
Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEX
J. Biol. Chem., September 26, 2003; 278(39): 37419 - 37426.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
Y. Kida, S. Fukumoto, T. Yamashita, K. Jonsson, M. Econs, and H. Juppner
Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia
N. Engl. J. Med., July 31, 2003; 349(5): 505 - 506.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
L. D. Quarles
FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization
Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E1 - E9.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
H. S. Tenenhouse and H. Murer
Disorders of Renal Tubular Phosphate Transport
J. Am. Soc. Nephrol., January 1, 2003; 14(1): 240 - 247.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online